Rajesh Narendran
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rajesh Narendran sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Rajesh Narendran: 5 sponsored US clinical trials, 3 recruiting.
Rajesh Narendran sponsors 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cocaine Use Disorder, with 2 trials.
Upper-quartile sponsor footprint
Rajesh Narendran sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Imaging CRF X NOP Interactions in Alcohol Use Disorder
NCT07612631
[C-11]NPA PET-amphetamine in Cocaine Use Disorders
NCT05011760
Imaging CRF X NOP Interactions in CUD
NCT05008146
[C-11]NOP-1A and Alcohol Use Disorder
NCT03448016
Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence
NCT01904487
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
Therapeutic Areas
What is open in the Rajesh Narendran pipeline
3 recruiting of 5 indexed (60% open); 2 completed (40%).
Phase mix: 0 late (III/IV) vs 5 early (I/II) (early-phase heavy).
Top condition: Cocaine Use Disorder (2 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rajesh Narendran: open-pipeline peers nationwide
Peers matched on 5 registered trials and 60% open enrollment, not the therapeutic-area sidebar.
Rajesh Narendran sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 60% open enrollment (± trial volume)
- Alaska Native Tribal Health Consortium · 60% recruiting · 5 trials
- Anwaar Saeed · 60% recruiting · 5 trials
- Autolus Limited · 60% recruiting · 5 trials
- Beam Therapeutics · 60% recruiting · 5 trials
Related
What to do with this Rajesh Narendran page
5 registered trials is a research-attention snapshot, not an endorsement of Rajesh Narendran or any single study.
- 3 of Rajesh Narendran's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cocaine Use Disorder is the condition Rajesh Narendran studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cocaine Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rajesh Narendran pipeline card: 5 registered trials from official public datasets.Report a data error.